Celera Corporation
Celera Elects Peter Barton Hutt to Board of Directors
Published in Medical Letter on the CDC and FDA, September 14th, 2008
Peter Barton Hutt is a senior counsel in the Washington, DC law firm of Covington & Burling, specializing in Food and Drug Law. He began his law practice with the firm in 1960 and, except for his four years with the Food and Drug Administration (FDA), has continued working at the firm. From 1971 to 1975 he was Chief Counsel for the FDA. Since 1994, he has taught a course on Food and Drug Law at Harvard Law School. He is the co-author of Food and Drug Law: Cases and Materials and has published more than 175 book chapters and articles on food and drug law and on...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Bioterrorism
Paper Reveals New Way to Combat Bioterror Agents - Drug Resistance
PolyMedix Initiates Dosing in Phase I Clinical Study of Novel Systemic Antibiotic Compound - Life Sciences
Studies conducted at M. Joner et al on life sciences recently published - NexMed, Inc.
NexMed Announces Decision for NM100060 - The Medicines Company
New Publication Shows Cleviprex is Safe and Effective for Treatment of Acute, Severe Hypertension - Valeant Pharmaceuticals International
Valeant Pharmaceuticals and GlaxoSmithKline Announce Worldwide Collaboration Agreement for Retigabine - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
